Table 4.
Pathogen | Peptide (μg/ml) | |||||||
---|---|---|---|---|---|---|---|---|
pepD | pepD2 | pepD3 | SP10-5 | |||||
MIC | MBC | MIC | MBC | MIC | MBC | MIC | MBC | |
Eco DH5α | 8 | 8 | 4 | 8 | 8 | 16 | 8 | 16 |
Xev Xvt28 | 4 | 16 | 4 | 4 | 4 | 4 | 8 | 8 |
Xcc Xcc17 | 2 | 8 | 1 | 1 | 2 | 2 | 2 | 2 |
Xoo Xoo28 | 4 | 4 | 4 | 8 | 4 | 4 | 8 | 8 |
Atu C58C1 | 4 | – | 2 | 2 | 2 | 2 | 2 | 4 |
Pcc | 32 | – | 8 | 16 | 8 | 16 | 16 | 16 |
Pst DC3000 | 16 | 32 | 4 | 8 | 8 | 16 | 8 | 16 |
Pss B728a | 32 | – | 8 | 16 | 8 | 16 | 8 | 32 |
“–” indicates that no antimicrobial activity was detected in rich media at the highest peptide concentration (32μg/ml) that was tested in this study.